Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China

By Pan Chang-Yu  

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 397-405

Adis International

Access to resources Recommend Favorite

Evaluation of the Efficacy and Tolerability of Acarbose in Patients with Diabetes Mellitus: A Postmarketing Surveillance Study

By Spengler M.   Schmitz H.   Landen H.  

Clinical Drug Investigation, Vol. 25, Iss. 10, 2005-01 ,pp. : 651-659

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance Study of the Efficacy and Tolerability of Pioglitazone in Insulin-Resistant Patients with Type 2 Diabetes Mellitus in General Practice

By Schöfl C.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 725-734

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

By Neuser Dieter  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 579-587

Adis International

Access to resources Recommend Favorite

Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus

By Segal Pesach  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 589-595

Adis International

Access to resources Recommend Favorite